期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

奥沙利铂联合亚叶酸钙和氟尿嘧啶治疗晚期胃癌临床观察 被引量：2

Clinical Observation on Oxaliplatin plus Calcium Folinate and Fluorouracil for Late Gastric Cancer
下载PDF
导出
摘要 目的:观察奥沙利铂联合亚叶酸钙和氟尿嘧啶治疗晚期胃癌的临床疗效。方法:28例经证实为胃癌的患者给予奥沙利铂、亚叶酸钙、氟尿嘧啶联合治疗。结果及结论:总有效率为34.6%,CF+5-Fu+L-OHP的联合化疗方案已被广泛接受,不良反应较轻微,值得临床应用观察。 OBJECTIVE： To observe the clinical efficacy of oxaliplatin plus calcium folinate and fluorouracil for Late gastric cancer. METHODS： A total of 28 cases with gastric carcinoma were assigned to receive oxaliplatin concomitantly with calcium folinate and fluorouracil. RESULTS ＆ CONCLUSION： The total effective rate was 34.6%. The combined chemotherapy of CF ＋ 5 - Fu ＋ L - OHP has been widely accepted since it involves little adverse reaction, thus it deserves to be applied and observed in the clinic.
作者 施仲义
机构地区 浙江省温州市中医院
出处 《中国医院用药评价与分析》 2006年第3期169-170,共2页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 奥沙利铂 亚叶酸钙 氟尿嘧啶 晚期胃癌 临床疗效 oxaliplatin calcium folinate fluorouracil late gastric cancer clinical efficacy
分类号 R979.1 [医药卫生—药品]
  • 相关文献

参考文献3

  • 1Preusser P,Wilke H,Achterrath W,et al.Phase Ⅱ study with the combination etopside,doxorubicin,and cisplatin in advanced easurable gastric cancer[J].J Clin Oncol,1989,7:1 310.
  • 2Wilke H,Preusser P,Fink U,et al.New developments in the treatment of gastric cancer[J].Semin Oncol,1990,17(1suppl 2):61.
  • 3张红宇,吴昌平.奥沙利铂联合亚叶酸钙和氟尿嘧啶治疗晚期胃癌[J].中国肿瘤,2005,14(7):485-486. 被引量：12

二级参考文献4

共引文献11

同被引文献15

  • 1Wagner AD, Grothe W, Haerting J, et al. Chemotherapy in advanced gastric cancer: a systemic review and meta - analysis based on aggregate data [ J ]. J Clin Oncol, 2006, 24 ( 18 ) :2 903.
  • 2Ajani JA. Docetaxel in combination for advanced gastric cancer[ J]. Gastric Cancer, 2002, 5 ( Suppl 1 ) :31.
  • 3Greenlee RT, Murray T, Bolden S, et al. Cancer statistics, 2000[J]. CA Cancer J Clin, 2000, 50(1) :7.
  • 4Van Custem E, Moiseyenko VM, Tjulandin S, et al. Phase Ⅲ study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first line therapy for advanced gastric cancer: a report Of the V325 study group[J]. J Clin Oncol, 2006, 24(31 ) : 4 991.
  • 5Roth DA, Maibach R, Falk S, et al. Docetaxel - cisplatin - 5 FU (TCF) versus docetaxel - cisplatin ( TC ) versus epirubicin - cisplatin - 5FU (ECF) in systemic treatment for advanced gastric carcinoma ( AGC ) : A randomized phase Ⅱ trial of the Swiss Group for Clinical Cancer Research (SAKK) [J]. Proc Am Soc Clin Oncol, 2004, 23:317 (Abstr 4 020).
  • 6Di Lauro L, Belli F, Arena MG, et al. Epirubicin, cisplatin and docetaxel combination therapy for metastatic gastric cancer[ J ]. Ann Oncol, 2005,16 (9) : 1 498.
  • 7Cunningham D, Starling N, Rao S, et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer[ J]. N Engl J Med, 2008, 358:36.
  • 8Al - Batran SE, Hartmann JT, Probst S, et al. Phase Ⅲ trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin : a study of the Arbeitsgemeinschaft Internistische Onkologie [ J ]. J Clin Oncol, 2008, 26 (9) :1 435.
  • 9Andre T, Louvet C, Ychou M, et al. Docetaxel - epirubicin as secondline treatment for patient with advanced gastric cancer [ J]. Proc Am Soc Clin Oncol, 1999, 18: 277a (Abstr 1 062).
  • 10Camps C, Massuti B, Jimenez A, et al. Randomized phase Ⅲ study of 3 - weekly versus weekly docetaxel in pretreated advanced non - small - cell lung cancer: a Spanish Lung Cancer Group trial[ J]. Ann Oncol, 2006, 17(3) :467.

引证文献2

二级引证文献4

中国医院用药评价与分析
2006年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部